CCTL019B2003I: Managed Access Program (MAP) to provide access to CTL019, for acute lymphoblastic leukemia (ALL) in diffuse large b-cell lymphoma (DLBCL) patients with out of specification leukapheresis product and/or manufactured tisagenlecleucel out of specification for commercial release
- Title
- Managed Access Program (MAP) to provide access to CTL019, for acute lymphoblastic leukemia (ALL) in diffuse large b-cell lymphoma (DLBCL) patients with out of specification leukapheresis product and/or manufactured tisagenlecleucel out of specification for commercial release
- Principal Investigator
- Veltri, Lauren
- Phase
- NA
- Age Group
- Adult
- Applicable Disease Sites
- Leukemia
- Lymphoma
- Participating Institutions
- Mary Babb Randolph Cancer Center
- Contacts
- Crystal Peck, RN
- BMT Coordinator
- Phone: +1 304-598-4500
- Email: peckc@wvumedicine.org